JAZZ
Jazz Pharmaceuticals PLC
222.50$
-3.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.0% | -5.2% | +4.9% | +4.4% | +6.0% | +1.9% | +12.6% | -6.2% | +1.5% | +6.7% | +5.1% | +0.7% | +8.2% | -8.1% | +5.2% | +6.8% | +10.8% | -8.7% | +23.7% | +11.5% | +7.0% | -9.3% | +14.6% | +0.8% | +3.3% | -8.2% | +7.2% | +1.5% | +4.1% | -10.9% | +13.5% | +3.0% | +3.1% | -17.5% | +16.5% | +7.7% | +6.4% | -10.8% | +13.0% | – | |
| – | +38.4% | -25.5% | +14.4% | +8.8% | -19.1% | +34.3% | +2.3% | -23.4% | -0.9% | +27.2% | -17.4% | +13.5% | +12.6% | -18.9% | -2.3% | +50.3% | +19.2% | -19.9% | +196.6% | +21.8% | -6.2% | -15.3% | +7.7% | +7.6% | +25.2% | -23.1% | -24.2% | +4.7% | +153.3% | -63.1% | +15.1% | +1.6% | +15.3% | -18.7% | +11.1% | +121.7% | -90.4% | +1,143.1% | -62.0% | – | |
| – | +3.7% | -3.3% | +4.2% | +4.1% | +8.0% | -0.1% | +13.4% | -4.9% | +1.7% | +5.5% | +6.7% | 0.0% | +7.9% | -7.4% | +5.6% | +4.6% | +10.1% | -7.8% | +11.5% | +9.5% | +9.8% | -8.2% | +15.8% | -0.2% | -0.3% | -5.0% | +12.5% | +1.2% | -13.4% | +7.1% | +13.3% | +3.2% | +1.7% | -17.3% | +17.2% | -6.6% | +35.1% | -35.0% | +43.2% | – | |
| – | -7.6% | +1.7% | -10.6% | +17.9% | +39.3% | -5.0% | -10.4% | -8.9% | +10.7% | +6.1% | +3.8% | +28.0% | +21.9% | -11.6% | -8.3% | -0.3% | +16.6% | -16.5% | +73.3% | +6.3% | +10.2% | -16.4% | +7.0% | +7.1% | +15.9% | +9.8% | +10.5% | +12.0% | -7.6% | +2.9% | -0.9% | -9.4% | +20.3% | -24.9% | +5.2% | +26.7% | -28.8% | -21.8% | +54.7% | – | |
| – | +1.0% | +14.9% | -8.3% | -5.9% | +14.9% | +44.9% | -23.5% | -1.7% | +3.8% | +3.8% | +4.8% | +1.5% | +19.9% | -2.7% | -8.2% | +8.3% | +19.3% | +5.4% | +64.7% | -15.2% | +9.6% | -22.5% | +18.7% | -2.2% | +6.9% | -22.3% | +14.4% | -9.5% | +28.5% | -11.2% | -3.7% | -3.8% | +13.4% | +39.2% | -30.3% | +48.1% | -23.4% | -13.2% | +10.3% | – | |
| – | -7.6% | +8.8% | -6.6% | +46.6% | -8.2% | +19.6% | -3.2% | -18.7% | +4.3% | +28.6% | -11.4% | +23.5% | +30.0% | +43.4% | -51.7% | +7.8% | +21.9% | -8.3% | +73.3% | -5.4% | +7.0% | -14.1% | +18.4% | +8.2% | -11.4% | -7.9% | +10.0% | -0.6% | -21.0% | +34.4% | -3.5% | -4.4% | +12.5% | +10.5% | +90.3% | -49.8% | -67.4% | +107.8% | +53.8% | – | |
| – | +21.5% | -17.7% | +21.2% | -47.6% | +63.3% | -37.8% | +74.5% | +23.2% | -2.0% | -27.7% | +52.7% | -34.8% | -54.0% | -409.7% | – | -1.0% | -11.6% | -6.5% | -142.9% | – | +74.1% | +77.3% | -2.3% | -71.1% | +350.7% | +12.9% | +25.1% | +9.4% | +17.3% | -67.3% | +201.2% | +30.5% | -26.7% | -129.3% | – | – | +1,481.0% | -76.5% | +16.1% | – | |
| – | +3.4% | -1.5% | -2.9% | +4.9% | +11.6% | -3.8% | -4.7% | -3.7% | -5.4% | +0.1% | +1.7% | -2.0% | +2.1% | +1.4% | +41.7% | +4.6% | +0.5% | -0.7% | +153.6% | +34.5% | -5.1% | -20.2% | -10.6% | +27.0% | -7.6% | +0.0% | -0.9% | -2.7% | +25.4% | -26.3% | -6.2% | -5.4% | -12.7% | +4.8% | -11.8% | +2.6% | -6.5% | +39.4% | -41.4% | – | |
| – | +29.9% | -23.4% | +22.0% | -54.1% | +83.1% | -45.1% | +97.8% | +30.9% | -2.4% | -30.6% | +60.3% | -38.2% | -65.1% | -629.8% | – | -1.2% | -13.9% | -3.0% | -196.3% | – | – | – | +749.9% | -437.8% | – | – | +48.1% | +24.4% | -38.3% | -104.8% | – | +45.4% | -33.6% | -182.8% | – | – | +2,205.3% | +43.7% | -29.5% | – | |
| – | +18.0% | -15.1% | +21.8% | -96.5% | -9,273.0% | – | +90.8% | -47.0% | -73.4% | +466.0% | -370.1% | – | -416.6% | – | – | -64.8% | -44.2% | +67.4% | +1,168.8% | -107.9% | – | – | -3,106.0% | – | – | – | – | – | – | – | -362.7% | – | – | – | – | – | – | +25.1% | +196.7% | – | |
| – | +33.9% | -25.9% | +22.1% | -39.8% | +265.5% | -80.2% | +100.7% | +61.7% | +6.8% | -46.6% | +207.4% | -60.9% | -27.7% | -313.3% | – | +29.1% | -10.0% | -8.7% | -398.2% | – | – | – | +2,004.7% | -156.7% | – | – | +50.4% | +40.6% | -35.9% | -115.5% | – | +27.6% | -11.1% | -148.4% | – | – | -19.1% | +44.1% | -34.2% | – | |
| – | +8.6% | -20.5% | +19.0% | +7.9% | -2.8% | -29.8% | +76.3% | -5.9% | +22.5% | -14.8% | +8.5% | -7.3% | -5.0% | -9.7% | +24.4% | +3.3% | +1.2% | -16.4% | -65.1% | +131.7% | +172.3% | -34.1% | -6.9% | -6.4% | -16.1% | +38.5% | -9.2% | +6.6% | +8.3% | -25.7% | +35.2% | +16.9% | -6.5% | -65.0% | -470.3% | – | +83.5% | +25.7% | -21.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.